GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

BlinkLab BB1.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.57

+0.88%

Close of 6 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in AUD, from our data supplier.

FY2026

Revenue

—

FY2022FY2026

Net income

−A$7.2m

FY2022FY2026

Free cash flow

—

FY2022FY2026

Shareholders' equity

A$19.5m

FY2022FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022
Revenue—A$375,550A$36,960——
Research and developmentA$4.7mA$2.6mA$180,125——
Operating income−A$8.4m−A$5.7m−A$1.7m−A$675,060−A$483,150
Net income−A$7.2m−A$5.7m−A$1.8m−A$676,380−A$485,150
Diluted earnings per share-0.05-0.05-0.02-0.01-0.00

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022
Total assetsA$20.6mA$9.7mA$6.9mA$370,130A$911,490
Cash and short-term investments—A$8.7mA$6.0mA$50,060A$616,910
Total liabilitiesA$1.1mA$700,730A$386,180A$329,410A$194,390
Debt—A$57,980A$111,850A$5,250A$16,560
Shareholders' equityA$19.5mA$9.0mA$6.5mA$40,720A$717,100
Shares outstanding153m124m99m99m99m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022
Cash from operations—−A$4.2m−A$1.8m−A$473,340−A$303,330
Capital spending−A$1.3m−A$135,520−A$143,960−A$83,070−A$264,860
Free cash flow—−A$4.3m−A$1.9m−A$556,410−A$568,190

Latest quarters

By quarter end

Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022
RevenueA$160,600A$215,220A$160,330————
Operating income−A$3.8m−A$3.5m−A$2.2m−A$1.6m−A$142,900−A$339,200−A$335,800
Net income−A$3.8m−A$3.5m−A$2.2m−A$1.6m−A$143,320−A$339,800−A$336,600
Diluted earnings per share-0.03-0.03-0.02-0.02-0.00-0.00-0.00
Cash from operations−A$3.0m−A$4.0m−A$1.0m−A$1.0m———
Total assets—A$9.7m—A$6.9mA$1.3mA$370,130A$621,230
Cash and short-term investments———A$6.0mA$1.0mA$50,060A$295,510
Debt———A$111,850—A$5,250A$10,140
Shareholders' equity—A$9.0m—A$6.5mA$1.2mA$40,720A$380,510

Growth per year

Compound annual rate

3 years5 years10 years
Operating income132.0%——
Net income120.2%——

Valuation history

At each fiscal year end

FY2026FY2025FY2024
Price to earnings-12.0-17.6-15.8
Price to sales—268.2—

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.